Simcyp® Simulator is the industry-leading physiologically-based pharmacokinetic (PBPK) platform developed over 25 years in collaboration with a consortium of more than 35 leading pharmaceutical companies worldwide. It is the first and only EMA Qualified PBPK platform for three contexts of use and is widely used to support critical R&D decisions and regulatory submissions, including label claims in lieu of clinical studies.
Simcyp Simulator’s key features include:
- Extensive libraries on demographics, developmental physiology, and drug elimination pathways
- Advanced mechanistic organ models and compound files
- Virtual population simulations across diverse demographics, ethnicities, and disease states
- Over 30 population libraries and more than 100 small and large molecule models
- Ability to support compound and population verification documents for regulatory submissions
In this webinar, Simcyp experts provide an overview of the key features and highlight the latest scientific advancements in Version 25, demonstrating how ongoing R&D innovation keeps Simcyp at the forefront of PBPK modeling and helps teams increase certainty and accelerate timelines.
